跳至主要内容
临床试验/KCT0007807
KCT0007807尚未招募未知

Effectiveness of Cilostazol on Cognitive Decline in High-risk Elderly PeOple with Ischemic Stroke Compared to Aspirin or ClopidogrEl

Seoul National University Bundang Hospital0 个研究点目标入组 2,362 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
2,362

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
65(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. History of ischemic stroke (more than 3 months ago)
  • 2. At high risk of dementia
  • (1) Aged 75 years and older,
  • (2) Aged 65-74 years and meeting one of the following conditions:
  • (i) diabetes mellitus
  • (ii) severe WMH (Fazekas grade III)
  • (iii) medial temporal atrophy (Scheltens’ visual grade III or more)
  • (iv) multiple cerebral microbleeds (=5)
  • (v) multiple lacunes (>5)
  • (vi) APOE e4 allele (+)
  • 3. patients signed informed consent

排除标准

  • 1. Subjects who are illiterate or have neurological deficits to a degree that would interfere with cognitive tests including hearing difficulty, poor cooperation, or severe aphasia.
  • 2. Subjects who have severe disability (e.g., modified Rankin scale > 3)
  • 3. Subjects who have dementia or major psychiatric illness (e.g., schizophrenia, bipolar disorder, major depression) at the time of randomization
  • 4. Subjects who have compelling indication for anticoagulation or dual antiplatelet therapy
  • 5. Subjects who have medical conditions that make it impossible to follow them up for 5 years (e.g., malignancies with life expectance less than 5 years)

研究者

相似试验

Effectiveness of Cilostazol on Cognitive Decline in... | 临床试验